Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

29.99 -0.88 (-2.85%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enovis Corporation Common Stock

< Previous 1 2 3 4 Next >
News headline image
3 Reasons to Avoid ENOV and 1 Stock to Buy Instead
Over the last six months, Enovis’s shares have sunk to $30.86, producing a disappointing 14.8% loss - a stark contrast to the S&P 500’s 16.3% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks
News headline image
The 5 Most Interesting Analyst Questions From Enovis’s Q3 Earnings Call
Enovis’ third quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market reacted negatively to the report. Management highlighted strong organic growth across the... 
Via StockStory
Topics Earnings World Trade
News headline image
Q3 Earnings Outperformers: Enovis (NYSE:ENOV) And The Rest Of The Medical Devices & Supplies - Specialty Stocks
Looking back on medical devices & supplies - specialty stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
News headline image
ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the... 
Via StockStory
Topics World Trade
News headline image
Enovis’s (NYSE:ENOV) Q3 Sales Top Estimates
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the... 
Via StockStory
News headline image
Enovis Corp (NYSE:ENOV) Posts Mixed Q3 Results with EPS Beat and Revenue Miss ↗
Enovis Q3 2025: Adjusted EPS beats estimates, but revenue slightly misses. The company raises full-year profit guidance despite a large non-cash charge. 
Via Chartmill
News headline image
Enovis (ENOV) Q3 Earnings: What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Russell 2000 Stock Worth Your Attention and 2 We Avoid
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
Why Enovis (ENOV) Stock Is Trading Up Today
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the afternoon session after the company announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity... 
Via StockStory
Topics Artificial Intelligence Economy Government
News headline image
Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
Enovis (ENOV) Stock Trades Up, Here Is Why
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 4.3% in the afternoon session after the company announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity... 
Via StockStory
Topics World Trade
News headline image
3 Value Stocks with Open Questions
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
News headline image
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics Economy Government World Trade
News headline image
1 of Wall Street’s Favorite Stock to Consider Right Now and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q2
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
News headline image
1 Russell 2000 Stock with Exciting Potential and 2 Facing Headwinds
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
3 Volatile Stocks We Approach with Caution
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
News headline image
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
News headline image
ENOV Q2 Deep Dive: New CEO Prioritizes Organic Growth, Margin Expansion, and Product Pipeline
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.5% year on year to $564.5 million. The company’s full-year... 
Via StockStory
News headline image
Enovis’s (NYSE:ENOV) Q2 Sales Beat Estimates, Stock Jumps 10.3%
Medical technology company Enovis Corporation (NYSE:ENOV) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.5% year on year to $564.5 million. The company’s... 
Via StockStory
Topics Earnings
News headline image
Enovis Corp (NYSE:ENOV) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss ↗
Enovis Corp (ENOV) reported mixed Q2 2025 results, with revenue slightly missing estimates but adjusted EPS beating forecasts. Shares rose 6.9% pre-market as the company raised full-year guidance. 
Via Chartmill
News headline image
Enovis (ENOV) Q2 Revenue Rises 7% ↗
Via The Motley Fool
Topics Earnings
News headline image
Enovis Earnings: What To Look For From ENOV
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.